Search research articles
Contact Us
Filters
Showing results (1-10 of 102) with videos related to
Page
of 11
Sort By:
Plos One
|
December 24, 2010
VKORC1 common variation and bone mineral density in the Third National Health and Nutrition Examination Survey
Dana C Crawford, Kristin Brown-Gentry, Mark J Rieder
Pharmacogenomics
|
May 1, 2007
Identifying the genotype behind the phenotype: a role model found in VKORC1 and its association with warfarin dosing
Dana C Crawford, Marylyn D Ritchie, Mark J Rieder
Nature Genetics
|
June 24, 2008
Estimating coverage and power for genetic association studies using near-complete variation data
Tushar R Bhangale, Mark J Rieder, Deborah A Nickerson
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|
January 17, 2015
Measures of exposure impact genetic association studies: an example in vitamin K levels and VKORC1
Dana C Crawford, Kristin Brown-Gentry, Mark J Rieder
Plos Genetics
|
September 13, 2006
Allele frequency matching between SNPs reveals an excess of linkage disequilibrium in genic regions of the human genome
Michael A Eberle, Mark J Rieder, Leonid Kruglyak, et al.
Physiological Genomics
|
March 8, 2007
Functional polymorphism in human CYP4F2 decreases 20-HETE production
David E Stec, Richard J Roman, Averia Flasch, et al.
Human Molecular Genetics
|
November 5, 2004
Comprehensive identification and characterization of diallelic insertion-deletion polymorphisms in 330 human candidate genes
Tushar R Bhangale, Mark J Rieder, Robert J Livingston, et al.
Human Genetics
|
May 9, 2006
Efficient selection of tagging single-nucleotide polymorphisms in multiple populations
Bryan N Howie, Christopher S Carlson, Mark J Rieder, et al.
Drug Metabolism Reviews
|
May 9, 2008
The environmental genome project: reference polymorphisms for drug metabolism genes and genome-wide association studies
Mark J Rieder, Robert J Livingston, Ian B Stanaway, et al.
Molecular Pharmacology
|
March 20, 2009
CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant
Matthew G McDonald, Mark J Rieder, Mariko Nakano, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 102) with videos related to
Sort By:
Page
of 11
Plos One
|
December 24, 2010
VKORC1 common variation and bone mineral density in the Third National Health and Nutrition Examination Survey
Dana C Crawford, Kristin Brown-Gentry, Mark J Rieder
Pharmacogenomics
|
May 1, 2007
Identifying the genotype behind the phenotype: a role model found in VKORC1 and its association with warfarin dosing
Dana C Crawford, Marylyn D Ritchie, Mark J Rieder
Nature Genetics
|
June 24, 2008
Estimating coverage and power for genetic association studies using near-complete variation data
Tushar R Bhangale, Mark J Rieder, Deborah A Nickerson
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|
January 17, 2015
Measures of exposure impact genetic association studies: an example in vitamin K levels and VKORC1
Dana C Crawford, Kristin Brown-Gentry, Mark J Rieder
Plos Genetics
|
September 13, 2006
Allele frequency matching between SNPs reveals an excess of linkage disequilibrium in genic regions of the human genome
Michael A Eberle, Mark J Rieder, Leonid Kruglyak, et al.
Physiological Genomics
|
March 8, 2007
Functional polymorphism in human CYP4F2 decreases 20-HETE production
David E Stec, Richard J Roman, Averia Flasch, et al.
Human Molecular Genetics
|
November 5, 2004
Comprehensive identification and characterization of diallelic insertion-deletion polymorphisms in 330 human candidate genes
Tushar R Bhangale, Mark J Rieder, Robert J Livingston, et al.
Human Genetics
|
May 9, 2006
Efficient selection of tagging single-nucleotide polymorphisms in multiple populations
Bryan N Howie, Christopher S Carlson, Mark J Rieder, et al.
Drug Metabolism Reviews
|
May 9, 2008
The environmental genome project: reference polymorphisms for drug metabolism genes and genome-wide association studies
Mark J Rieder, Robert J Livingston, Ian B Stanaway, et al.
Molecular Pharmacology
|
March 20, 2009
CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant
Matthew G McDonald, Mark J Rieder, Mariko Nakano, et al.
Page
of 11